Go to Content
  1. Home
  2. Activities
  3. Small Business and Startup Support
  4. bitBiome, Inc.

bitBiome, Inc.
Technological Enhancements and Business Validation Toward International Development of Microbial Gene Database

bitBiome, Inc. logo

As of March 2024

City Year of Establishment Founder
Shinjuku, Tokyo 2018 Masahito Hosokawa, Ph. D.
Partner VC Latest round of Fundraising Valuation
- Series B2 Non-Disclosure
  • Contact Information : 03-6205-5662
  • info@bitbiome.bio
  • Website : a new window will openbitBiome, Inc.

Program name

Deep-Tech Startups Support Program

Research theme

Technological Enhancements and Business Validation Toward International Development of Microbial Gene Database

Business Plan

bitBiome, Inc. contributes to solving R&D and production issues in the bio-manufacturing industry through the realization of the discovery and improvement of optimal genes by using our core technologies: the one and only single-cell genome analysis technology "bit-MAP®", a vast and highly accurate microbial genome database "bit-GEM", an enzyme discovery and modification platform with world-class accuracy and speed "bit-QED". This grant project aims to support entry into the primary market for biomanufacturing utilizing microbial gene resources in the United States. It involves the improvement of our microbial single-cell genome sequencing technologies that enable efficient analysis of overseas environmental samples.

Research Outline

In this R&D effort, we will improve our existing microbial genome analysis technology to enable efficient analysis of environmental samples, adapt it to the U.S. market, and also demonstrate its performance and feasibility for commercialization.

Phase Business Area/Field Research Period Research Grant Amount
PCA Food & Agricuture 2023～2027 FY JPY 440 million

International collaborative technology demonstration

Countries/Regions Collaborative activity outline
United States
  • - Local base establishment
  • - Supply chain develop
Through the international demonstration activities, we will investigate the feasibility of commercialization in the U.S. market, clarify the necessary technical specifications, and then improve the technology and implement it overseas. The following activities will be undertaken: 1) research on business feasibility and regulations, 2) development of lab or office in the U. S., and 3) demonstration of microbial genome analysis and genetic data collection performance of overseas environmental samples using the improved technology.

Last Updated : October 15, 2024